Navigation Links
'Chemo Brain' After Breast Cancer Backed by Study
Date:9/7/2012

FRIDAY, Sept. 7 (HealthDay News) -- Breast cancer patients treated with chemotherapy are at risk for mild mental deficits known collectively as "chemo brain," a new study finds.

Researchers at the Moffitt Cancer Center in Tampa, Fla., reviewed existing research on brain function ("cognitive" functioning) in breast cancer patients who received standard doses of chemotherapy for at least six months.

The analysis revealed that, on average, these patients had mild impairments in verbal abilities (such as difficulty choosing words) and visual-spatial abilities (such as getting lost more easily).

Mental functioning varied among the patients, with some reporting no problems and others reporting more severe or widespread impairments, the investigators found.

The study was published online Aug. 27 in the Journal of Clinical Oncology.

"Breast cancer patients treated with chemotherapy who have subsequent cognitive deficits should be referred to a neuropsychologist for evaluation and management of the deficits," lead author Heather Jim, whose research focuses on the psychosocial and behavioral aspects of cancer survivorship, said in a Moffitt news release.

"Management usually involves developing an awareness of the situations in which their cognitive difficulties are likely to arise so that they can come up with strategies to compensate," she explained. "Research shows that such strategies can make a big difference in daily life when cognitive difficulties do arise."

More information

The American Cancer Society has more about chemo brain.

-- Robert Preidt

SOURCE: Moffitt Cancer Center, news release, Sept. 4, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
2. Adding bavituximab to second-line chemotherapy doubles response rate
3. Review finds some evidence for chemo brain in breast cancer survivors, Moffitt Cancer Center says
4. More heart problems with 2 chemo drugs for breast cancer
5. Immunodeficient patients with secondary lung disease benefit from combined chemotherapy
6. Chemo During Pregnancy Doesnt Seem to Harm Newborn
7. Mechanisms of acquired chemoresistance in ovarian cancer identified
8. Breast cancer patients who lack RB gene respond better to neoadjuvant chemotherapy
9. Certain Heart Meds May Give Chemo a Boost
10. Specialized MRI scans assess value of anti-cancer chemotherapy long before tumors shown to shrink
11. RLIP76 contributes to pancreatic cancer cell resistance to chemotherapy and radiation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Chemo Brain' After Breast Cancer Backed by Study
(Date:2/22/2017)... ... February 22, 2017 , ... ... of a new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided ... nation’s largest healthcare systems recently invested $51 million to purchase and renovate the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem ... recent years. The technology is so cutting edge, in fact, the U.S. Food ... stem cell procedures. However, successful patient outcomes in certain clinical stem cell procedures ...
(Date:2/22/2017)... ... 2017 , ... The National Academy of Certified Care Managers ... 2017 testing period. NACCM, a nonprofit organization, has provided the premier certification for ... periodically re-calibrated to ensure that newly certified professionals are prepared to work effectively ...
(Date:2/22/2017)... TX (PRWEB) , ... February ... ... Risk Adjustment solution leverages advanced data analytics to accurately understand each Medicare ... proper reimbursement for a given population. This new solution helps transform the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its steady expansion ... H. Rauchman, practicing at North Valley Eye Medical Group in Mission Hills . ... and other personal injury cases. These injuries have a major impact on the ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Spheryx, Inc. ... poster presentation at PittCon 2017 Conference and ... is the world,s largest annual premier conference ... a wide array of industry, academic and ... and QA, food safety, environmental, bioterrorism and ...
(Date:2/23/2017)... Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ( www.provectusbio.com ... dermatology biopharmaceutical company, today announced that it has appointed ... as special advisers to the Company,s Board of Directors.  ... on financial and corporate strategy. Provectus also ... up to $2.5 million from Eric Wachter , ...
(Date:2/23/2017)... DEERFIELD, Ill. , Feb. 23, 2017 /PRNewswire/ ... a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) ... Cognition Holdings PLC and Ctrl Group Limited, announced a ... app on an Apple Watch wearable to monitor and ... (MDD). Depression (MDD) is the leading cause ...
Breaking Medicine Technology: